Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 7 | 2021 | 44 | 1.370 |
Why?
|
| Genomics | 7 | 2021 | 109 | 0.820 |
Why?
|
| Universities | 1 | 2021 | 34 | 0.730 |
Why?
|
| Genome, Human | 4 | 2021 | 25 | 0.460 |
Why?
|
| Genetic Variation | 6 | 2021 | 175 | 0.400 |
Why?
|
| Africa | 7 | 2021 | 376 | 0.380 |
Why?
|
| Software | 2 | 2021 | 37 | 0.360 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2020 | 198 | 0.290 |
Why?
|
| Genetics, Population | 4 | 2021 | 52 | 0.230 |
Why?
|
| Gene Flow | 2 | 2021 | 9 | 0.220 |
Why?
|
| Language | 2 | 2021 | 14 | 0.220 |
Why?
|
| Humans | 16 | 2021 | 14537 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 176 | 0.200 |
Why?
|
| Keratosis | 2 | 2013 | 4 | 0.200 |
Why?
|
| Skin Diseases, Genetic | 2 | 2013 | 4 | 0.200 |
Why?
|
| Erythema | 2 | 2013 | 5 | 0.200 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 11 | 0.190 |
Why?
|
| Diffusion of Innovation | 1 | 2021 | 10 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 22 | 0.190 |
Why?
|
| International Cooperation | 1 | 2021 | 50 | 0.180 |
Why?
|
| United States | 1 | 2021 | 132 | 0.180 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 18 | 0.180 |
Why?
|
| Schools | 1 | 2021 | 73 | 0.180 |
Why?
|
| Fluoroacetates | 1 | 2020 | 2 | 0.180 |
Why?
|
| Magnoliopsida | 1 | 2020 | 3 | 0.180 |
Why?
|
| Stress, Mechanical | 1 | 2020 | 16 | 0.180 |
Why?
|
| Transcriptome | 1 | 2020 | 14 | 0.170 |
Why?
|
| Plant Leaves | 1 | 2020 | 13 | 0.170 |
Why?
|
| Health | 1 | 2020 | 11 | 0.170 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 6 | 0.170 |
Why?
|
| Demography | 1 | 2021 | 105 | 0.170 |
Why?
|
| Human Migration | 1 | 2020 | 8 | 0.170 |
Why?
|
| Proteome | 1 | 2020 | 5 | 0.170 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 13 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 9 | 0.170 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 25 | 0.170 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 106 | 0.170 |
Why?
|
| Adaptation, Biological | 1 | 2018 | 5 | 0.150 |
Why?
|
| Computer-Assisted Instruction | 1 | 2017 | 1 | 0.140 |
Why?
|
| Internet | 1 | 2017 | 12 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 5 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2017 | 22 | 0.140 |
Why?
|
| DNA | 1 | 2017 | 73 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2017 | 49 | 0.130 |
Why?
|
| Mutation | 3 | 2017 | 306 | 0.120 |
Why?
|
| Farnesyl-Diphosphate Farnesyltransferase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cathepsin B | 1 | 2011 | 2 | 0.090 |
Why?
|
| Geography | 2 | 2021 | 60 | 0.090 |
Why?
|
| Whole Genome Sequencing | 2 | 2020 | 44 | 0.080 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2009 | 2 | 0.080 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2009 | 3 | 0.080 |
Why?
|
| Haplotypes | 2 | 2021 | 125 | 0.080 |
Why?
|
| Male | 4 | 2021 | 6754 | 0.070 |
Why?
|
| South Africa | 6 | 2021 | 7596 | 0.070 |
Why?
|
| Selection, Genetic | 2 | 2020 | 31 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 41 | 0.070 |
Why?
|
| Evolution, Molecular | 2 | 2018 | 60 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2021 | 122 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 34 | 0.060 |
Why?
|
| Female | 3 | 2021 | 9103 | 0.050 |
Why?
|
| Alleles | 2 | 2014 | 143 | 0.050 |
Why?
|
| Linguistics | 1 | 2021 | 5 | 0.050 |
Why?
|
| Chromosomes, Human, Y | 1 | 2021 | 9 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2020 | 2 | 0.040 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2020 | 3 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2020 | 4 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 4 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2020 | 3 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 27 | 0.040 |
Why?
|
| Metabolism | 1 | 2020 | 3 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 23 | 0.040 |
Why?
|
| History, Ancient | 1 | 2020 | 6 | 0.040 |
Why?
|
| Immunity | 1 | 2020 | 10 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 6 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 22 | 0.040 |
Why?
|
| DNA Repair | 1 | 2020 | 11 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 15 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 7 | 0.040 |
Why?
|
| Genetics, Medical | 1 | 2020 | 21 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2020 | 32 | 0.040 |
Why?
|
| Microbiota | 1 | 2021 | 30 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 20 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 106 | 0.040 |
Why?
|
| Phylogeny | 1 | 2021 | 231 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 199 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 370 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 468 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 480 | 0.040 |
Why?
|
| Genetics | 1 | 2018 | 3 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2018 | 9 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2018 | 9 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 217 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 18 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 20 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2017 | 6 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 967 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 4 | 0.030 |
Why?
|
| Protein Domains | 1 | 2017 | 10 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 64 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2017 | 5 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 43 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 84 | 0.030 |
Why?
|
| Nigeria | 1 | 2017 | 49 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 179 | 0.030 |
Why?
|
| Base Sequence | 1 | 2017 | 149 | 0.030 |
Why?
|
| Aged | 1 | 2020 | 1740 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2014 | 3 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2014 | 27 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 400 | 0.030 |
Why?
|
| Parakeratosis | 1 | 2013 | 2 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 11 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 22 | 0.030 |
Why?
|
| Middle Aged | 1 | 2020 | 3601 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2011 | 3 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2011 | 4 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2011 | 7 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2011 | 13 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 18 | 0.020 |
Why?
|
| Founder Effect | 1 | 2011 | 16 | 0.020 |
Why?
|
| Introns | 1 | 2009 | 13 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 17 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2009 | 14 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2009 | 34 | 0.020 |
Why?
|